发明名称 CD4+CD25+ REGULATORY T CELL OF HUMAN BLOOD ORIGIN
摘要 <p><P>PROBLEM TO BE SOLVED: To provide inhibitory and/or regulatory human CD4<SP>+</SP>CD25<SP>+</SP>T cells, a method for proliferating the T cells, and a method for utilizing the inhibitory and/or regulatory human CD4<SP>+</SP>CD25<SP>+</SP>T cells or the proliferated T cells as a regulating agent. <P>SOLUTION: The inhibitory and/or regulatory human CD4<SP>+</SP>CD25<SP>+</SP>T cells are isolated from human peripheral blood by the magnetic separation or immune adsorption method, preferably by the suitable monoclonal antibody. The T cells are CTLA-4<SP>+</SP>and have regulatory characteristics. The method for proliferating the T cells includes a step of stimulating the cells ex vivo and in vivo with the T cell stimulant or the antigen presenting cells. <P>COPYRIGHT: (C)2011,JPO&INPIT</p>
申请公布号 JP2011041570(A) 申请公布日期 2011.03.03
申请号 JP20100228383 申请日期 2010.10.08
申请人 ALGOS THERAPEUTICS INC 发明人 SCHULER GEROLD;DIECKMANN DETLEF
分类号 C12N5/0783;A61K35/12;A61K35/14;A61P37/00;A61P37/02;A61P37/04;A61P37/06;C12Q1/02;G01N33/15;G01N33/50;G01N33/53 主分类号 C12N5/0783
代理机构 代理人
主权项
地址